Estimation of the sensitivity and specificity of assays for screening antibodies to HIV: A comparison between the frequentist and Bayesian approaches

Journal of Virological Methods

Volumn 186, Issue 1-2, 2012, Pages 89-93

  Liu, Pei ^a   Yang, Hai Tao ^b   Qiang, Lai Ying ^c   Xiao, San ^a   Shi, Zhi Xu ^d  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Xuzhou Blood Center   (China)

Author keywords

Bayesian approach; Frequentist approach; Screening for antibodies to HIV; Sensitivity and specificity

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACCURACY; ANTIBODY DETECTION; ARTICLE; AUSTRALIA; BAYES THEOREM; CHINA; CONTROLLED STUDY; FREQUENCY ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS; INDIA; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIMULATION; TANZANIA; UNITED STATES; WORLD HEALTH ORGANIZATION;

CLINICAL LABORATORY TECHNIQUES; HIV ANTIBODIES; HUMANS; IMMUNOASSAY; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 84869011255     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.08.018     Document Type: Article

References (31)

1. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiologic Perspectives & Innovations 2004, 1:6.
2. Agresti A., Coull B.A. Approximate is better than exact for interval estimation of binomial proportions. The American Statistician 1998, 52:119-126.
3. Anuradha K., Ponamgi S.P., Lakshmi V. Evaluation of two commercially available anti human immunodeficiency virus antibody Elisa Kits using clinical samples. Indian Journal of Medical Microbiology 2002, 20:102-104.
4. Basáñez M.G., Marshall C., Carabin H., Gyorkos T., Joseph L. Bayesian statistics for parasitologists. Trends in Parasitology 2004, 20:85-91.
5. Beelaert G., Vercauteren G., Fransen K., Mangelschots M., De Rooy M., Garcia-Ribas S., van der Groen G. Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. Journal of Virological Methods 2002, 105:197-206.
6. Berkvens D., Speybroeck N., Praet N., Adel A., Lesaffre E. Estimating disease prevalence in a Bayesian framework using probabilistic constraints. Epidemiology 2006, 17:145-153.
7. Congdon P. Normal linear regression, general linear models and log-linear models. Bayesian Statistical Modeling 2006, John Wiley & Sons, Chichester, UK.
8. Dendukuri N., Joseph L. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 2001, 57:158-167.
9. Dunson D. Practical advantages of Bayesian analysis of epidemiologic data. American Journal of Epidemiology 2001, 153:1222-1225.
10. Efron B. Bayesians, frequentists, and scientists. JASA 2005, 100:1-5.
11. Geurden T., Claerebout E., Vercruysse J., Berkvens D. Estimation of diagnostic test characteristics and prevalence of Giardia duodenalis in dairy calves in Belgium using a Bayesian approach. International Journal for Parasitology 2004, 34:1121-1127.
12. Geurden T., Berkvens D., Geldhof P., Vercruysse J., Claerebout E. A Bayesian approach for the evaluation of six diagnostic assays and the estimation of Cryptosporidium prevalence in dairy calves. Veterinary Research 2006, 37:671-682.
13. Goldstein H., Browne W., Rasbash J. Multilevel modelling of medical data. Statistics in Medicine 2002, 21:3291-3315.
14. Iregbu K.C., Esfandiari J., Nnorom J., Sonibare S.A., Uwaezuoke S.N., Eze S.O., Abdullahi N., Lawal A.O., Durogbola B.S. Dual path platform HIV 1/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria. Diagnostic Microbiology and Infectious Disease 2011, 69:405-409.
15. Liu P., Yang H.T., Qiang L.Y., Jin H., Xiao S., Shi Z.X. Evaluation of 30 commercial assays for the detection of antibodies to HIV in China using classical and Bayesian statistics. Journal of Virological Methods 2010, 170:73-79.
16. Liu P., Xiao S., Shi Z.X., Bi X.X., Yang H.T., Jin H. Bayesian evaluation of the human immunodeficiency virus antibody screening strategy of duplicate enzyme-linked immunosorbent assay in Xuzhou Blood Center, China. Transfusion 2011, 51:793-798.
17. Lyamuya E.F., Aboud S., Urassa W.K., Sufi J., Mbwana J., Ndugulile F., Massambu C. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infectious Diseases 2009, 9:19.
18. Nauta J. Statistics in Clinical Vaccine Trials 2011, Springer, Heidelberg Dordrecht London New York.
19. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Statistics in Medicine 1998, 17:857-872.
20. Ntzoufras I. Introduction to Bayesian inference. Bayesian Modeling Using WinBugs 2009, John Wiley & Sons, Inc., Hoboken New Jersey.
21. Qiang L.Y. A National Assessment of Clinical Quality of Diagnostic Assays to HIV Antibodies in China 2006, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, http://www.chinacdc.net.cn/n272442/n272530/n272712/15825.html.
22. Santos â., Clemente S., Bártolo I., Palladino C., Cavaco-Silva P., Franco V., Epalanga M., Pinto R., Taveira N. Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic. Diagnostic Microbiology and Infectious Disease 2011, 71:90-92.
23. Silvester C., Healey D.S., Cunningham P., Dax E.M. Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays, Australian HIV Test Evaluation Group. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1995, 8:411-419.
24. Spiegelhalter, D., Thromas, A., Best, N., Lunn, D. 2003. WinBUGS User Manual (Version 1.4). (accessed). http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/manual14.pdf.
25. Syed Iqbal H., Balakrishnan P., Murugavel K.G., Suniti S. Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2. Journal of Clinical Laboratory Analysis 2008, 22:178-185.
26. UNAIDS, 1998. HIV ASSAYS. Operational characteristics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera. (accessed). http://www.who.int/diagnostics_laboratory/publications/Report16_final.pdf.
27. UNAIDS, 2004. HIV ASSAYS: operational characteristics (phase 1) report 14 simple/rapid tests. (accessed). http://www.who.int/diagnostics_laboratory/publications/en/hiv_assays_rep_14.pdf.
28. UNAIDS, 1997. Revised recommendations for the selection and use of HIV antibody test. http://www.who.int/docstore/wer/pdf/1997/wer7212.pdf.
29. Urassa W.K., Bredberg-Rådén U., Mbena E., Pålsson K., Minja E., Lema R.A., Pallangyo K., Mhalu F.S., Biberfeld G. Alternative confirmatory strategies in HIV-1 antibody testing. Journal of Acquired Immune Deficiency Syndrome 1992, 5:170-176.
30. Vollset S.E. Confidence intervals for a binomial proportion. Statistics in Medicine 1993, 12:809-824.
31. Wijeysundera D.N., Austin P.C., Hux J.E., Beattie W.S., Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. Journal of Clinical Epidemiology 2009, 62:13-21.